Christopher W. Boyce
31Patents
7h-index
110Co-inventors
68Inventor score
Filing activity: Oct 15, 2001 → Aug 20, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7220735B2 | Benzimidazolone histamine H3 antagonists | Chemistry; Metallurgy | 24 | Expired |
| US7638531B2 | Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists | Chemistry; Metallurgy | 18 | Active |
| US7105505B2 | Benzimidazole derivatives useful as histamine H3 antagonists | Chemistry; Metallurgy | 16 | Expired |
| US8003624B2 | Functionally selective ALPHA2C adrenoreceptor agonists | Chemistry; Metallurgy | 11 | Active |
| US6720328B2 | Non-imidazole compounds | Chemistry; Metallurgy | 11 | Expired |
| US7300941B2 | Non-imidazole compounds | Chemistry; Metallurgy | 9 | Expired |
| US7803828B2 | Functionally selective alpha2C adrenoreceptor agonists | Chemistry; Metallurgy | 8 | Active |
| US7700592B2 | α2C adrenoreceptor agonists | Chemistry; Metallurgy | 6 | Active |
| US8383818B2 | Functionally selective alpha2C adrenoreceptor agonists | Chemistry; Metallurgy | 5 | Active |
| US8927559B2 | Quinazolinone-type compounds as CRTH2 antagonists | Chemistry; Metallurgy | 4 | Active |
| US9023865B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9884048B2 | ERK inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7846946B2 | Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists | Emerging Cross-Sectional Technologies | 1 | Active |
| US7635705B2 | Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists | Emerging Cross-Sectional Technologies | 1 | Active |
| US10011615B2 | Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties | Chemistry; Metallurgy | 1 | Active |
| US9469615B2 | Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US8470863B2 | Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists | Chemistry; Metallurgy | 0 | Active |
| US8017642B2 | Functionally selective ALPHA2C adrenoreceptor agonists | Human Necessities | 0 | Active |
| US11344496B2 | Methods for preparing stabilized amorphous drug formulations using acoustic fusion | Human Necessities | 0 | Active |
| US8476274B2 | Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US7985748B2 | ALPHA2C adrenoreceptor agonists | Chemistry; Metallurgy | 0 | Active |
| US8501747B2 | Functionally selective alpha2C adrenoreceptor agonists | Chemistry; Metallurgy | 0 | Active |
| US9233979B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9290453B2 | Quinolines and aza-quinolines as CRTH2 receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US9745307B2 | Compounds that are ERK inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.